Earnings
HAE
117.06
+2.89%
3.29
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-03-28
137.31M
--
--
165.21M
--
--
0.00
--
270.28M
--
29.63M
1.22M
603.64M
305.63M
--
--
--
210.65M
133.11M
--
14.08M
663.47M
1.27B
--
50.73M
0.00
--
--
--
--
--
73.35M
--
--
--
73.76M
274.82M
305.51M
--
--
10.56M
89.10M
405.18M
680.00M
503.00K
553.23M
78.51M
--
--
--
587.11M
587.11M
1.27B
FY 2019-03-30
169.35M
--
--
185.03M
--
--
0.00
--
194.34M
--
26.13M
1.28M
576.12M
343.98M
--
--
--
210.82M
127.69M
--
16.16M
698.65M
1.27B
--
63.36M
0.00
--
--
--
--
--
65.65M
--
--
--
79.09M
235.76M
322.45M
--
--
19.91M
28.78M
371.14M
606.90M
510.00K
536.32M
161.42M
--
--
--
667.87M
667.87M
1.27B
FY 2018-03-31
180.17M
--
--
151.23M
--
--
0.00
--
160.80M
--
27.88M
1.10M
521.18M
332.16M
--
--
--
211.40M
156.59M
--
16.02M
716.16M
1.24B
--
55.27M
0.00
--
--
--
--
--
77.79M
--
--
--
57.39M
384.70M
59.42M
--
--
6.53M
34.26M
100.21M
484.91M
523.00K
503.95M
266.94M
--
--
--
752.43M
752.43M
1.24B
FY 2017-04-01
139.56M
--
--
152.68M
--
--
0.00
--
176.93M
--
38.93M
1.93M
510.03M
323.86M
--
--
--
210.84M
177.54M
--
16.44M
728.68M
1.24B
--
42.97M
0.00
--
--
--
--
--
51.99M
--
--
--
55.19M
211.18M
253.63M
--
--
12.11M
22.18M
287.92M
499.10M
523.00K
482.04M
289.92M
--
--
--
739.61M
739.61M
1.24B
FY 2016-04-02
115.12M
--
--
157.09M
--
--
0.00
--
187.03M
--
28.41M
427.00K
488.09M
337.63M
--
--
--
267.84M
204.46M
--
21.11M
831.04M
1.32B
--
39.67M
0.00
--
--
--
--
--
40.96M
--
--
--
61.44M
185.55M
364.53M
--
--
21.38M
26.11M
412.01M
597.56M
509.00K
439.91M
316.18M
--
--
--
721.57M
721.57M
1.32B

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out HAE latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Haemonetics recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.